+

Cookies on the Business Insider India website

Business Insider India has updated its Privacy and Cookie policy. We use cookies to ensure that we give you the better experience on our website. If you continue without changing your settings, we\'ll assume that you are happy to receive all cookies on the Business Insider India website. However, you can change your cookie setting at any time by clicking on our Cookie Policy at any time. You can also see our Privacy Policy.

Close
HomeQuizzoneWhatsappShare Flash Reads
 

2 top experts resigned from a key panel after the FDA approved a new Alzheimer's drug

Jun 10, 2021, 19:18 IST
Business Insider
FDAAndrew Harnik/AP Photo

Hello,

Advertisement

Welcome to Insider Healthcare. I'm Lydia Ramsey Pflanzer, and today in healthcare news:

If you're new to this newsletter, sign up here. Comments, tips? Email me at lramsey@insider.com or tweet @lydiaramsey125. Let's get to it...

Two doctors have resigned from a prestigious panel after FDA approved a controversial Alzheimer's drug

Get the scoop here>>

Amazon/Handout via Reuters

Amazon and Walmart are competing to offer you the cheapest prescriptions, and it could shake up the entire pharmacy industry

Find out more>>

Advertisement

Glen Tullman, Livongo's former CEO, and Lee Shapiro, an original Livongo investor, celebrate during the company's initial public offering in 2019.Livongo

A startup backed by Livongo veterans just got a nearly $500 million valuation, and it's coming for healthcare's middlemen

Read the full exclusive here>>

More stories we're reading:

- Lydia

You are subscribed to notifications!
Looks like you've blocked notifications!
Next Article